TridentCare Closes Acquisition of Shoreline Diagnostics, Solidifying Its California Presence With a Market-Leading Clinical Lab
-
Stocks, gold rise as investors weigh AI boom, political turmoil
-
Swiatek coasts through Wuhan debut while heat wilts players
-
Denmark's Rune calls for heat rule at Shanghai Masters
-
Japanese football official sentenced for viewing child sexual abuse images
-
Stocks, gold steady amid political upheaval
-
'Veggie burgers' face grilling in EU parliament
-
Trio wins physics Nobel for quantum mechanical tunnelling
-
Two years after Hamas attack, Israelis mourn at Nova massacre site
-
German factory orders drop in new blow to Merz
-
Man City star Stones considered retiring after injury woes
-
Kane could extend Bayern stay as interest in Premier League cools
-
Renewables overtake coal but growth slows: reports
-
OpenAI's Fidji Simo says AI investment frenzy 'new normal,' not bubble
-
Extreme rains hit India's premier Darjeeling tea estates
-
Raducanu retires from opening match in Wuhan heat with dizziness
-
UK's Starmer condemns pro-Palestinian protests on Oct 7 anniversary
-
Tokyo stocks hit new record as markets extend global rally
-
Japan's Takaichi eyes expanding coalition, reports say
-
Canadian PM to visit White House to talk tariffs
-
Indonesia school collapse toll hits 67 as search ends
-
Dodgers hold off Phillies, Brewers on the brink
-
Lawrence sparks Jaguars over Chiefs in NFL thriller
-
EU channels Trump with tariffs to shield steel sector
-
Labuschagne out as Renshaw returns to Australia squad for India ODIs
-
Open AI's Fidji Simo says AI investment frenzy 'new normal,' not bubble
-
Tokyo stocks hit new record as Asian markets extend global rally
-
Computer advances and 'invisibility cloak' vie for physics Nobel
-
Nobel literature buzz tips Swiss postmodernist, Australians for prize
-
Dodgers hold off Phillies to win MLB playoff thriller
-
China exiles in Thailand lose hope, fearing Beijing's long reach
-
Israel marks October 7 anniversary as talks held to end Gaza war
-
Indians lead drop in US university visas
-
Colombia's armed groups 'expanding,' warns watchdog
-
Shhhh! California bans noisy TV commercials
-
New to The Street Client Partner Roadzen's DrivebuddyAI Secures EU General Safety Regulation 2144 Compliance
-
Jericho Energy Ventures and Smartkem Sign Letter of Intent to Create U.S.-Owned, Nasdaq-Listed AI-Focused Infrastructure Company
-
Medical Care Technologies (OTC Pink:MDCE) Outlines Regulatory Roadmap: Dividing AI Health Platform Into Clinical and Consumer Divisions
-
Lithium Corporation Clarifies Corporate Identity Following Rare Earths Exploration Milestone
-
SMX Brings Compliance Into High-Fashion Through Game-Changing CETI Collaboration (NASDAQ:SMX)
-
Art's Way Reports Improved Results With Modular Buildings Growth Offsetting Ag Market Challenges
-
Konica Minolta Unleashes Comic Book Magic at PRINTING United Expo
-
Inovatec to Showcase Industry-Leading Funding Automation Technology at Auto Finance Summit 2025
-
IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease
-
American Resources Corporation's ReElement Technologies Advances as Finalist for National Science Foundation Award as Part of the Critical Materials Crossroads Consortium
-
Green Rain Energy Holdings Inc. (OTCID:$GREH) Integrates EV Infrastructure at 8757 Rio San Diego Drive with Major SDG&E Utility Upgrade
-
New to The Street Announces 12-Month National Media Partnership with Stardust Power (NASDAQ: SDST)
-
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit
-
Leeward Group Expands Offering with Launch of Leeward Trust
-
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA
-
Angkor Resources Completes First Onshore Seismic Program in Cambodia; Vanderbilt Report Publishes Coverage
NYSE - LSE
| RIO | -0.34% | 66.75 | $ | |
| GSK | -0.38% | 43.285 | $ | |
| SCS | -0.06% | 16.97 | $ | |
| NGG | -0.43% | 73.58 | $ | |
| CMSC | 0% | 23.8 | $ | |
| VOD | -0.31% | 11.255 | $ | |
| RBGPF | 0% | 78.22 | $ | |
| AZN | 0.44% | 85.865 | $ | |
| BCE | -0.43% | 23.085 | $ | |
| RYCEF | -2.15% | 15.37 | $ | |
| BP | -0.54% | 34.662 | $ | |
| CMSD | -0.29% | 24.37 | $ | |
| JRI | 0.04% | 14.186 | $ | |
| BCC | 1.2% | 76.09 | $ | |
| RELX | -2.41% | 45.32 | $ | |
| BTI | 0.88% | 51.635 | $ |
TridentCare Closes Acquisition of Shoreline Diagnostics, Solidifying Its California Presence With a Market-Leading Clinical Lab
"As an organization and harnessing our powerful, national platform, we are excited to add an in-market California lab to our national footprint," said Tomlinson. "We are excited to welcome the team from Shoreline to the existing TridentCare Lab family of over 300 phlebotomists and lab professionals in California. Existing Shoreline customers will experience uninterrupted and enhanced lab services from our expanded test menu and conversion of the lab to a 24/7 operation. Current TridentCare customers will also benefit from improved stat and routine test turnaround times."
SPARKS, MD / ACCESS Newswire / August 13, 2025 / TridentCare, the leading national provider of portable diagnostic services, has enhanced its laboratory presence in California with the acquisition of Shoreline Diagnostics. Shoreline Diagnostics, a CLIA-Certified, Full-Service Clinical Diagnostics Laboratory located in Irvine, CA, is known for providing "white glove," quality services to local facilities. The addition of Shoreline's dedicated team of clinicians and medical laboratory will complement and enhance the existing, highly experienced team at TridentCare in CA, led by industry veteran Chris Tomlinson, Senior Vice President, who remains focused on enhancing the national Lab delivery model, the overall quality of the customer experience and timely results across TridentCare's laboratory footprint.
"At Shoreline, one of our main goals as an organization is to improve access to high-quality care and make a meaningful difference in the lives of patients and their families," said Doug Bischoff, CEO, Shoreline Diagnostics. "We see an assured path to achieving this goal by joining forces with TridentCare, a nationally recognized and locally trusted portable diagnostic services provider. Those beyond our reach yesterday will benefit from this transaction and have increased access to care tomorrow, thanks to TridentCare."
About TridentCare
Based in Sparks, Maryland, TridentCare is the leading provider of portable diagnostic services in the country, operating in 42 states, servicing a wide variety of patients and clients. Each day, the company deploys experienced medical professionals and leading-edge technology to provide digital imaging, mobile phlebotomy, laboratory, and vascular services to tens of thousands of patients nationwide. For more information about TridentCare, please visit TridentCare.com, and follow us on LinkedIn and Instagram.
Contact Information
Deborah Shelton
[email protected]
SOURCE: TridentCare
View the original press release on ACCESS Newswire
A.Jones--AMWN